Related Experiment Video

Updated: Jul 1, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Design of Right-Handed D-Sulfonyl-γ-AApeptides with Broad-Spectrum Antimicrobial Activity

Xue Zhao1, Heng Liu1, Xiaoyang Lin2

  • 1Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, Florida 33620, United States.

Journal of Medicinal Chemistry
|June 30, 2026
PubMed

Insights

New sulfonyl-γ-AApeptides show broad-spectrum antibacterial activity against resistant pathogens. These novel antimicrobial peptidomimetics offer enhanced stability and reduced resistance, presenting a promising alternative to conventional antibiotics.

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Biotechnology

Background:

  • Antimicrobial resistance (AMR) is a global health crisis, diminishing antibiotic effectiveness.
  • Antimicrobial peptides (AMPs) show promise but face challenges like instability and toxicity.
  • Developing novel antimicrobial agents is crucial to combat multidrug-resistant pathogens.

Purpose of the Study:

  • To design and synthesize novel sulfonyl-γ-AApeptides as potential antimicrobial agents.
  • To evaluate the antibacterial spectrum, selectivity, and stability of these compounds.
  • To investigate the mechanism of action and in vivo efficacy of the lead compound.

Main Methods:

  • Synthesis of sulfonyl-γ-AApeptide foldamers.
  • In vitro antibacterial assays against Gram-positive and Gram-negative bacteria, including resistant strains.
  • Assessment of cytotoxicity, stability, antibiofilm activity, and resistance development.
  • In vivo efficacy study in a mouse model of MRSA infection.
  • Mechanistic studies involving membrane perturbation and reactive oxygen species (ROS) analysis.

Main Results:

  • The synthesized sulfonyl-γ-AApeptides demonstrated broad-spectrum antibacterial activity and a high selectivity index.
  • The lead compound, AM10, exhibited potent bactericidal activity, rapid kinetics, strong antibiofilm effects, and minimal resistance development.
  • AM10 showed exceptional stability and effectively reduced bacterial burden in a mouse MRSA infection model.
  • Mechanistic studies indicated membrane perturbation and ROS accumulation as key action modes.

Conclusions:

  • Sulfonyl-γ-AApeptide foldamers represent a promising new class of antimicrobial peptidomimetics.
  • The lead compound AM10 displays favorable properties for combating drug-resistant bacterial infections.
  • This platform holds potential for developing next-generation antimicrobial therapies.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

Related Concept Videos

Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...